Monthly versus three doses malaria chemoprophylaxis in pregnancy at Lautech Teaching Hospital Osogbo, a randomised controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202304768950531

Enrollment

242

Registered

2023-04-04

Start date

2021-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria MALARIA IN PREGNANCY

Interventions

ARM A

ARM B

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (a) All pregnant women who consented irrespective of their age or gravidity (b) Pregnancy at the second trimester but not more than 20weeks (c) No history of allergic reaction to sulphonamides

Exclusion criteria

Exclusion criteria: Positive test for VDRL, diabetics, and hypertension (essential or pregnancy induced) (b) Severe anaemia (PCV <20%) (c) Multiple pregnancy as determined by an ultrasound scan report (d) Other severe illness that could require hospitalization. e) Reaction to Sulphonamides

Design outcomes

Primary

Measure	Time frame
Plavental malaria detection and ;Birth Weight and Low birth weight;Gestational Age at delivery and Preterm Births	—

Secondary

Measure	Time frame
Neonates' packed cell volume and Anaemia;Maternal Packed Cell Volume and Anaemia;Cord Blood Malaria detection;Detection and Treatment of Pregnant women for symptomatic Malaria in pregnancy	—

Countries

Nigeria

Contacts

Public ContactADENIYI;OLUFEMI FASANU;ALA

CONSULTANT;CONSULTANT

pekun2001@yahoo.co.uk;alaolufemi248@gmail.com2348033857553;2348036896773

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026